Table III.
Association of putative risk factors with BL risk in participants aged 20–59 years and 60+ years.
20–59 years | 60+ years | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Case (N=69) | Control (N=268) | OR (95% CI) | P | aOR (95% CI)* | P | Case (N=60) | Control (N=232) | OR (95%CI) | P | aOR (95% CI)** | P | |
BMI† | ||||||||||||
T1 | 14 | 40 | Ref. | 17 | 55 | Ref. | ||||||
T2 | 12 | 42 | 0.80 (0.32 – 2.04) | 0.65 | 12 | 58 | 0.64 (0.27 – 1.53) | 0.31 | ||||
T3 | 14 | 40 | 1.07 (0.44 – 2.56) | 0.89 | 13 | 55 | 0.80 (0.35 – 1.84) | 0.60 | ||||
Missing | 29 | 146 | N/A | 18 | 64 | N/A | ||||||
Trend | 0.63 | 0.73 | ||||||||||
| ||||||||||||
Smoking | ||||||||||||
Never | 32 | 54 | Ref. | Ref. | 15 | 41 | Ref. | Ref. | ||||
Former | 22 | 111 | 0.25 (0.12 – 0.50) | 0.001 | 0.22 (0.09 – 0.52) | <0.001 | 41 | 134 | 0.76 (0.36 – 1.58) | 0.61 | 0.61 (0.27 – 1.34) | 0.22 |
Current | 11 | 74 | 0.20 (0.09 – 0.46) | <0.001 | 0.12 (0.04 – 0.35) | <0.001 | 3 | 45 | 0.18 (0.05 – 0.67) | 0.01 | 0.14 (0.03 – 0.58) | 0.007 |
Missing | 4 | 29 | N/A | N/A | N/A | 1 | 12 | N/A | N/A | |||
Ptrend | <.0001 | <0.001 | 0.013 | 0.007 | ||||||||
| ||||||||||||
Any Infection | ||||||||||||
Never | 13 | 76 | Ref. | 7 | 27 | Ref. | ||||||
Ever | 56 | 192 | 1.76 (0.87 – 3.54) | 0.12 | 53 | 205 | 0.95 (0.37 – 2.47) | 0.92 | ||||
| ||||||||||||
Hepatitis | ||||||||||||
Never | 56 | 232 | Ref. | 54 | 223 | Ref. | Ref. | |||||
Ever | 13 | 36 | 1.59 (0.77 – 3.31) | 0.21 | 6 | 9 | 3.41 (1.01 – 11.5) | 0.05 | 3.21 (0.89 – 11.6) | 0.08 | ||
| ||||||||||||
EBV | ||||||||||||
Never | 62 | 263 | Ref. | Ref. | 58 | 230 | Ref. | Ref. | ||||
Ever* | 7 | 5 | 5.60 (1.78 – 17.6) | 0.003 | 5.69 (1.29 – 25.1) | 0.021 | 2 | 2 | 4.00 (0.56 – 28.4) | 0.17 | 11.8 (0.96 – 144.2) | 0.05 |
| ||||||||||||
HIV/AIDS | ||||||||||||
Never | 53 | 264 | Ref. | Ref. | 57 | 232 | ||||||
Ever* | 16 | 4 | 20.6 (5.98 – 70.7) | <0.001 | 40.4 (7.74 – 211.1) | <0.0001 | 3 | 0 | ||||
| ||||||||||||
Malaria | ||||||||||||
Never | 65 | 266 | Ref. | Ref. | 59 | 225 | Ref. | |||||
Ever | 4 | 2 | 8.00 (1.46 – 43.7) | 0.016 | 44.0 (2.63 – 735.3) | 0.008 | NS | NS | 0.57 (0.07 – 4.64) | 0.60 | ||
| ||||||||||||
Use of Prednisone | ||||||||||||
Never | 67 | 262 | Ref. | 53 | 225 | Ref. | Ref. | |||||
Ever | 2 | 6 | 1.33 (0.27 – 6.60) | 0.73 | 7 | 7 | 7.30 (1.81 – 29.4) | 0.009 | 7.78 (1.85 – 32.5) | 0.005 |
The estimates are from multivariable models including smoking, EBV, HIV/AIDS, malaria controlling for one another, and adjusted for years of observation in the CPRD.
The estimates are from multivariable models including smoking, hepatitis, EBV, use of prednisone controlling for one another, and adjusted for years of observation in the CPRD.
BMI tertile values for adults aged 20–59 years are: T1 (<24.63), T2 (>=24.63 to 28.88) and T3 (>28.88); the corresponding values for adults aged 60++ years are T1 (<25.57), T2 (>=25.57 to 28.74) and T3 (>=28.74)
Abbreviations: 95% CI: 95% Confidence Interval; AIDS: acquired immune deficiency syndrome; BL: Burkitt lymphoma; BMI: body mass index; CPRD: Clinical Practice Research Datalink; EBV: Epstein–Barr virus; HIV: human immunodeficiency virus; N/A; not applicable due to missing data; NS; cell numbers suppressed because one cell has one subject; OR: Odds ratio; P: P value for heterogeneity; Ptrend: P value for trend across categories; Ref.: Reference category